英文别名：
l-adrenaline bitartrate;(-)-epinephrine bitartrate;(-)-Noradrenaline bitartrate;(+)-epinephrine bitartrate;(R)-1-(3,4-dihydroxy-phenyl)-2-methylamino-ethanol, Lg-hydrogentartrate;ADRENAL, RAT;adrenalinbitartrate;Adrenaline hydrotartrate;Adrenaline tatrate;adrenalinetartrate;Adrenalinium;Asmatane mist (tn);D02149;epinephrinetartrate;Epinephrinhydrogentartrat;L-epinephrine bitartrate;Medihaler-epi (tn);Suprarenin tartrate;(-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur.;L-Epinephrine (Bitartrate);Bronkaid Mist Suspension;(-)-Adrenaline hydrogen tartrate;(2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;L-Epinephrine D-hydrogentartrate;HMS3884F06;YLXIPWWIOISBDD-NDAAPVSOSA-N;SW219274-2;DTXCID2029375;BCP9000650;(R)-(-)-Epinephrine bitartrate;EPINEPHRINE BITARTRATE (USP-RS);ADRENALIN TARTRATE [WHO-IP];L-epinephrine hydrogen tartrate;Adrenaline hydrogen tartrate;Bronitin Mist;SCHEMBL40741;Bronitin;Epinephrine Bitartrate, Pharmaceutical Secondary Standard; Certified Reference Material;l-Adrenaline d-bitartrate;Primatene Mist Suspension;Adrenaline acid tartrate, l-;16536-89-3;(-)-Epinephrine (+)-bitartrate;EINECS 200-097-1;1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt);L-Adrenaline tartrate;EPINEPHRINE BITARTRATE COMPONENT OF LIGNOSPAN FORTE;ADRENALINE ACID TARTRATE [MART.];Tox21_202839;ADRENALINE ACID TARTRATE (MART.);Adrenaline Tartrate (L-Adrenaline Tartrate);EPINEPHRINE TARTRATE;CCG-267841;EPINEPHRINE BITARTRATE [WHO-DD];CAS-51-42-3;EPINEPHRINE BITARTRATE (USP MONOGRAPH);adrenaline tartrate;Q27255971;(-)-Adrenaline bitartrate;UNII-30Q7KI53AK;l-Epinephrine tartrate;CHEBI:228805;epinephrinehydrogentartrate;CHEMBL1200818;Epinephrine bitartrate (USP:JAN);1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt);LIGNOSPAN FORTE COMPONENT EPINEPHRINE BITARTRATE;NSC 756755;(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;(-)-Adrenaline tartrate;4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (2R,3R)-2,3-dihydroxybutanedioate (1:1);Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard;Adrenaline acid tartrate;(-)-Epinephrine (+)-bitartrate salt, solid;ADRENALINE TARTRATE (EP MONOGRAPH);(-)-3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)BENZYL ALCOHOL (+)-TARTRATE (1:1) SALT.;EPINEPHRINE BITARTRATE [JAN];Adrenaline bitartate;Epinephrine bitartrate (Adrenalinium);Asthmahaler;Epinephrine d-bitartrate;Adrenaline acid tartrate, British Pharmacopoeia (BP) Reference Standard;l-Epinephrine d-bitartrate;51-42-3;AKOS015951390;Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard;(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt;NCGC00260385-01;Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard;Epinephrine bitartrate;EPINEPHRINE BITARTRATE [USP-RS];HY-B0447A;Adrenalin tartrate;s2521;EN300-12578730;EPINEPHRINE BITARTRATE [ORANGE BOOK];EPINEPHRINE BITARTRATE [USP MONOGRAPH];DTXSID3049415;Adrenaline bitartrate;Epinephrine acid tartrate;(-)-Adrenaline acid tartrate;ADRENALINE TARTRATE [EP MONOGRAPH];BCP0726000242;Epinephrine bitartrate (JAN/USP);Epinephrine bitartrate [USP:JAN];EPINEPHRINE BITARTRATE [VANDF];24351-82-4;EPINEPHRINE HYDROGEN TARTRATE [WHO-IP];l-Adrenaline hydrogen tartrate;Adrenaline (as tartrate);(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate;EPINEPHRINE D-BITARTRATE [MI];D88223;30Q7KI53AK;Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-;1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt);NSC-756755;EPINEPHRINI HYDROGENOTARTRAS [WHO-IP LATIN];(-)-Epinephrine-(+)-bitartrate;
Inchi：
1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
